Five things for pharma marketers to know: Thursday, July 9, 2020
Coronavirus cases in U.S. pass 3 million; Walgreens partners with VillageMD; Biogen submits Alzheimer’s drug for FDA approval.
Most recent articles by Carrie Gavit
Five things for pharma marketers to know: Wednesday, July 8, 2020
Novavax receives $1.6b for COVID-19 vaccine; Trump begins process of withdrawal from WHO; PPE shortages return as cases spike.
Five things for pharma marketers to know: Tuesday, July 7, 2020
Doctors urge WHO to acknowledge airborne transmission of COVID-19; FDA approves Becton Dickinson’s rapid antigen test; Webcast: Leverage machine learning, AI to improve trial recruitment.
Five things for pharma marketers to know: Monday, July 6, 2020
MM&M Move Together five-day fitness challenge; #CreateHealthEquity: Convince the world access to quality healthcare is a fundamental human right; MM&M Online Expo virtual event.
Five things for pharma marketers to know: Thursday, June 25, 2020
Judge rules hospitals, insurers must disclose some pricing; Remdesivir could be priced at $5,080; Bayer settles Roundup lawsuits.
Five things for pharma marketers to know: Thursday, June 18, 2020
WHO cautions use of dexamethasone as COVID-19 treatment; MM&M’s #CreateHealthEquity initiative; Hydroxychloroquine dropped from WHO’s study of coronavirus treatments.
Five things for pharma marketers to know: Thursday, June 11, 2020
WHO was incorrect about asymptomatic carrier spread of COVID-19; Coronavirus cases spiking in reopened states; MM&M’s 2020 events go virtual.
